Notably, when mice with melanoma were treated with either WT or LPA5-/- tumor-specific CD8+ T cells, high numbers of CD8+ T cells were found only within the tumors of mice receiving LPA5-/- CD8+ T cells, and tumor growth was clearly reduced [118,119]. This evidence concerns the gene LPAR5 and melanoma.